ArticleEuropean journal of clinical pharmacology2009

The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.

Guo Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.